Pharmaceutical company Novartis has charted a significant expansion plan, signaling strategic growth and increased investment in its operations.

Novartis has confirmed its intention to acquire Excellergy, an allergy-drug developer, in a deal valued at up to $2 billion, with the Wall Street Journal providing further details and confirmation on the acquisition.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, which is expanding Zepbound access, along with Novo Nordisk and Novartis.

Pharmaceutical giant Novartis is reportedly set to acquire an experimental breast cancer drug in a deal valued at up to $3 billion, expanding its oncology pipeline.

Als Teil eines ausergewöhnlichen Pharma-Powerpaars sorgte sie für Aufsehen. Nun verlässt Srishti Gupta, die Ehefrau von Novartis-CEO Narasimhan, überraschend Idorsia.

Pharmaceutical company Novartis has unveiled a new share buyback program, signaling a move to return capital to shareholders.

Novartis has opened a new factory in Mengeš, Slovenia, which will initially produce active ingredients for breast cancer and rare blood disease medications, marking a significant milestone for the company.

Novartis is the second drug company to settle a lawsuit brought by the family of a woman whose cells have enabled huge advances in science.

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine

Aurobindo Pharma's subsidiary has received approval from the U.S. FDA for its generic version of a Novartis drug, marking a significant development for the company.

An article explores the potential of Novartis stock as a component for building a millionaire retirement portfolio.

An analysis of ship movements reveals that the Trump administration is isolating Cuba, leading to a vulnerable moment for the island nation.

Forlesia Cook, a grandmother who lost her grandson to gun violence, urged voters to prioritize causes over party loyalty in America while defending President Trump at a Black History Month event.

Pharmaceutical giant Novartis has announced its intention to purchase Excellergy, a developer of allergy drugs, in a deal valued at up to $2 billion, expanding its portfolio in the allergy treatment market.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, Novo Nordisk, and Novartis.

Novartis to boost multidimensional investments  China Daily

Novartis is offering high-grade debt to secure funding for its recently announced $12 billion acquisition deal with Avidity.

Die Rechtsunsicherheit unter Donald Trump sorgte 2025 für einen Lobbying-Boom. Auch Konzerne aus der Schweiz haben ihr Budget zum Teil deutlich aufgestockt, um in den USA gehört zu werden.

Novartis And Henrietta Lacks’ Family Reach A Settlement  Forbes

Avidity (RNA) has changed the date for its shareholder vote concerning the proposed merger with Novartis.

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine

Novartis announced plans to construct a new radioligand therapy manufacturing facility in Texas, aiming to expand its US production capabilities.

Novartis celebrates double recognition for clinical research excellence in Saudi Arabia  Arab News

Madrigal Pharmaceuticals experienced a stock sell-off, while a former Novartis executive moved to Daiichi.

Analysts are offering their projections on the future direction and performance of Novartis AG (NVS).

Novartis has publicly announced plans for additional investment in China, signaling its continued commitment to the market.

Several major corporate deals involving companies such as Ecolab, Novartis, and 3M have been highlighted this week in financial news.

Seiner Grossmutter wurden, ohne ihre Zustimmung, Tumorproben entnommen. Heute klagt Michael jene Pharmafirmen an, die damit forschen. Mit Novartis kam er jetzt zu einer Einigung.

Novartis, Nucor, and US Forged Rings are among several companies expanding their domestic investments, signaling a trend towards increased local economic activity and manufacturing.

Novartis has announced plans to establish a new manufacturing facility for radioligand therapy in Denton, Texas, expanding its production capabilities.

The family of Henrietta Lacks has reached a settlement with pharmaceutical company Novartis regarding the unauthorized use of her cells, which were taken without her consent in 1951.

Novartis and Genentech have filed a lawsuit against a U.S. company and a Canadian pharmacy, alleging illegal importation of a Canadian version of their allergy medicine.

Novartis announced plans to construct a new radioligand therapy manufacturing facility in Texas, aiming to expand its production capabilities within the United States.

An analysis suggests that pharmaceutical giant Novartis could be a stable, long-term core holding for investors.

Novartis has entered into a licensing agreement potentially worth up to $1.8 billion for oral peptide drugs.